Citigroup (C)

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

Estimated Future Benefit Payments

The Company expects to pay the following estimated benefit payments in future years:

In December 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the “Act of 2003”) was enacted. The Act of 2003 established a prescription drug benefit under Medicare known as “Medicare Part D,” and a federal subsidy to sponsors of U.S. retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. The benefits provided to certain participants are at least actuarially equivalent to Medicare Part D and, accordingly, the Company is entitled to a subsidy.

Estimated Future Benefit Payments

        The Company expects to pay the following estimated benefit payments in future years:

        In December 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the "Act of 2003") was enacted. The Act of 2003 established a prescription drug benefit under Medicare known as "Medicare Part D," and a federal subsidy to sponsors of U.S. retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. The benefits provided to certain participants are at least actuarially equivalent to Medicare Part D and, accordingly, the Company is entitled to a subsidy.

        With respect to this, Citigroup adopted FSP FAS 106-2 retroactive to the beginning of 2004. The expected subsidy reduced the accumulated postretirement benefit obligation (APBO) by approximately $130 million and $100 million as of January 1, 2005 and 2004, respectively, and the 2005 and 2004 postretirement expense by approximately $19 million and $11 million, respectively, for all of the postretirement welfare plans for 2005 and 2004. Additionally, as of December 31, 2005, an additional reduction in the plans' APBO of approximately $45 million was recognized to reflect the expected impact of the final Medicare regulations issued during 2005.

        The following table shows the estimated future benefit payments without the effect of the subsidy and the amounts of the expected subsidy in future years.

151

Citigroup 401(k)

        Under the Citigroup 401(k) plan, eligible employees receive matching contributions of up to 3% of their compensation, subject to an annual maximum of $1,500, invested in the Citigroup common stock fund. The pretax expense associated with this plan amounted to approximately $70 million in 2005, $69 million in 2004, and $65 million in 2003.